| | | | |

Japanese Discovery Could Lead to New Mesothelioma Blood Test

mesothelioma blood testA discovery in Japan could lead to a more effective mesothelioma blood test for mesothelioma diagnosis. Japanese scientists say they have found a better way to detect mesothelioma cells in the blood. 

The scientists are experts in occupational health. Malignant mesothelioma is an occupational cancer because people can get it from working near asbestos.

Mesothelioma diagnosis is challenging. But a powerful mesothelioma blood test could make it easier to find the asbestos cancer earlier. Treatment often works better when patients start it earlier.

Circulating Tumor Cells in the Blood of Mesothelioma Patients

No matter what kind of cancer a person has, their tumor releases some cells into the blood. Mesothelioma tumors are no exception.

These circulating tumor cells (CTCs) are one  of the ways that cancer can spread. When tumor cells “land” in a new location, they may seed a new tumor.

CTCs also offer another way for doctors to detect mesothelioma and other cancers.

Making a Mesothelioma Diagnosis

Unfortunately, there is no simple way to tell if a patient has malignant mesothelioma.

Right now, for a person to receive a mesothelioma diagnosis, a doctor must run many tests. Imaging scans, biopsies, and blood tests are common ways doctors try to detect mesothelioma.

Patients also have to tell their doctor about any possible exposure to asbestos. Asbestos is the number one cause of mesothelioma around the world.

In Search of a Mesothelioma Blood Test

Finding mesothelioma cells in the blood is challenging. The only FDA-cleared system for finding CTCs is called CellSearch. While CellSearch is good at finding some other types of cancer, it often misses mesothelioma cells.

In an article in Cancer Science, the Japanese team says their new system, called CTC-chip, is better at detecting mesothelioma.

CTC-chip is coated with an antibody against podoplanin. Podoplanin is a glycoprotein that is common in the blood of people with pleural mesothelioma.

Researchers tested CTC-chip on healthy blood that was spiked with mesothelioma cells. Then they tested it on the blood of mesothelioma patients.

“The CTC-chip showed superior CTC-detection performances over CellSearch in experimental models and in clinical samples,” reports lead research Kazue Yoneda.

In some cases, the mesothelioma blood test was even able to tell whether the tumor was operable. The more CTCs a mesothelioma patient had in their blood, the worse their prognosis.

More tests will be needed before the CCTC-chip would be available for use in mesothelioma diagnosis.

Source:

Yoneda, K, et al, “Detection of Circulating Tumor Cells with a Novel Microfluidic System in Malignant Pleural Mesothelioma”, November 30, 2018, Cancer Science, Epub ahead of print, https://doi.org/10.1111/cas.13895

Similar Posts

  • |

    Mesothelioma Still Rising Despite Ban in Ireland

    A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

  • |

    Website Aims to Protect Homeowners from Mesothelioma

    Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

  • | | |

    Mesothelioma Nurses Ready for New Cases in Australia

    Australia is bracing for an expected new wave of mesothelioma cases in the next decade and the Lung Foundation of Australia is taking action now to get ready. The Foundation has paid for ten nurses from around the country to receive specialized training in helping patients and families cope with mesothelioma. The nurses, who have recently completed the training, are now equipped to lead treatment planning for these complex cancer patients and to help other nurses do the same. Pleural mesothelioma is an aggressive cancer that occurs in the lining around the lungs. It is caused by exposure to asbestos dust, a toxin that was once alarmingly prevalent in Australia where it was mined and heavily used in construction. Because…

  • |

    Mesothelioma Blood Test May Be Possible

    An international team of researchers is studying the proteins found on the surface of cancer cells in an effort to improve mesothelioma diagnosis. The team, made up of scientists from the US, Switzerland, Italy and Chile, has just published their findings on a new kind of test to identify protein-derived mesothelioma biomarkers in blood serum. Mesothelioma is an aggressive cancer of the membranes around organs. Because the most common mesothelioma biomarker, mesothelin, is also overproduced by other kinds of cancer cells, it has only limited diagnostic value. A test to identify a set of proteins produced specifically by mesothelioma cells could greatly improve diagnostic accuracy. Led by Ferdinando Cerciello and Bernd Wollscheid of the Institute of Molecular Systems Biology in…

  • | |

    Spanish Mesothelioma Deaths Likely to Continue for Decades

    New research in Spain suggests that mesothelioma deaths will continue in the country until the “last surviving member” of the group of people exposed to occupational asbestos succumbs to the disease. Like many countries, Spain used asbestos heavily in the first half of the 20th century, especially in construction, where the mineral was prized for its durability, low cost, and resistance to fire and corrosion.  Asbestos was banned in Spain in 2002. Observing that more than 2.5 million metric tons of asbestos were imported into Spain from 1906 to 2002, researchers say deaths from mesothelioma have risen steadily. Between 1976 and 1980, a total of 491 Spanish people died of mesothelioma. By the 5-year period from 2006 to 2010, that…

  • | |

    Needle Biopsy “Simple, Safe & Accurate” for Mesothelioma

    Mesothelioma researchers in China say a biopsy method that involves a single skin puncture can produce good diagnostic results for mesothelioma patients with little pain or risk. The study focused on percutaneous (through the skin) biopsy in patients who had unexplained fluid buildup or swelling in their abdomens. Abdominal distension and fluid buildup (called ascites) can be signs of peritoneal mesothelioma, a rare but aggressive cancer of the abdominal lining caused by exposure to asbestos. Peritoneal mesothelioma accounts for less than 30% of all mesothelioma cases. Because the symptoms may be vague and often develop many decades after asbestos exposure, peritoneal mesothelioma can be especially challenging to diagnose.  Misdiagnosis and under-diagnosis are not uncommon. In the newest study on percutaneous…